Goldman

Analysts at Goldman downgrade Potash Inc (NYSE: POT) from "conviction buy" to "neutral." POT’s shares fell 0.88% to close at $28.05 yesterday. More Analyst Ratings here.

Analysts at Goldman downgrade TJX Companies (NYSE: TJX) from “conviction buy” to “buy.” Shares of TJX closed at $44.82 yesterday. More Analyst Ratings here.

Analysts at Goldman upgrade JC Penney (NYSE: JCP) from “neutral” to “conviction buy.” Shares of JCP closed at $30.98 yesterday. More Analyst Ratings here.

Analysts at Goldman upgrade KeyCorp (NYSE: KEY) from “neutral” to “buy.” Shares of KEY closed at $8.47 yesterday. More Analyst Ratings here.

Analysts at Goldman initiate coverage of Ameriprise (NYSE: AMP) with a “neutral” rating. The price target for AMP is set to $40. Shares of AMP closed at $46.17 on Thursday. More Analyst Ratings here.

Analysts at Goldman downgrade Monster Worldwide (NYSE: MWW) from “neutral” to “sell.” The price target for MWW is set to $14. Shares of MWW closed at $16.90 on Thursday. More Analyst Ratings here.

Analysts at Goldman Sachs initiate coverage of Public Service (NYSE: PEG) with a "neutral" rating. The target price for PEG is set to $34. PEG’s shares lost 0.14% to close at $29.45 yesterday. More Analyst Ratings here

Analysts at Goldman Sachs downgrade NRG Energy (NYSE: NRG) from "conviction buy" to "buy." NRG’s shares closed at $21.58 yesterday. More Analyst Ratings here

Analysts at Goldman Sachs downgrade RRI Energy (NYSE: RRI) from "buy" to "neutral." RRI’s shares closed at $4.18 yesterday. More Analyst Ratings here

Analysts at Goldman Sachs downgrade Teva Pharmaceutical (NASDAQ: TEVA) from "conviction buy" to "buy." The target price for TEVA is set to $67. According to Goldman Sachs, the downgrade in the rating is based on valuation. TEVA’s shares lost 0.96% to $60.40. More Analyst Ratings here

Analysts at Goldman Sachs downgrade Kimberly Clark (NYSE: KMB) from "sell" to "conviction sell." The target price for KMB has been reduced from $60 to $57. KMB’s shares lost 0.80% to trade at $59.87. More Analyst Ratings here

Analysts at Goldman Sachs downgrade Boston Scientific (NYSE: BSX) from "neutral" to "conviction sell." The target price for BSX is set to $6. BSX’ gained 1.47% to trade at $6.90. More Analyst Ratings here

Analysts at Goldman Sachs downgrade UnitedHealth (NYSE: UNH) from "conviction buy" to "buy." UNH’s shares dipped 1.01% to trade at $32.20. More Analyst Ratings here

Analysts at Goldman Sachs upgrade Onyx Pharma (NASDAQ: ONYX) from "neutral" to "buy." The target price for ONXX has been raised from $34 to $37. ONXX’s shares closed at $31.50 yesterday. More Analyst Ratings here

Analysts at Goldman Sachs upgrade Alexion Pharma (NASDAQ: ALXN) from "buy" to "conviction buy." The target price for ALXN has been raised from $57 to $62. ALXN’s shares closed at $52.85 yesterday. More Analyst Ratings here